Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Other
(-)
≠ Faculty of Science
(-)
= Smolen, J.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Other
(9)
+
-
Availability
Metadata Only
(9)
+
-
Creation Date
2011
(6)
+
-
2010
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(9)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(9)
+
-
Author
Heijde, D. van der
(9)
+
-
Strand, V.
(5)
+
-
Kavanaugh, A.
(4)
+
-
Keystone, E.
(4)
+
-
Landewe, R.
(4)
+
-
Vollenhoven, R. van
(4)
+
-
Ansari, Z.
(3)
+
-
Combe, B.
(3)
+
-
Goel, N.
(3)
+
-
Cifaldi, M.
(2)
+
-
Curtis, J.
(2)
+
-
Fichtner, A.
(2)
+
-
Fleischmann, R.
(2)
+
-
Goldring, M.
(2)
+
-
Guerette, B.
(2)
+
-
Luijtens, K.
(2)
+
-
Mease, P.
(2)
+
-
Patra, K.
(2)
+
-
Vencovsky, J.
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Landewe, R.; Keystone, E.; Smolen, J.; Goldring, M.; Guerette, B.; Patra, K.; ... ; Heijde, D. van der
2011
Disconnect Between Disease Activity and Joint Space Narrowing for Patients with Early Ra Treated with Adalimumab plus Methotrexate but not Methotrexate Alone: Case for Anti-Tnf Cartilage Protection
Other
metadata only
Smolen, J.; Vollenhoven, R. van; Kavanaugh, A.; Luijtens, K.; Heijde, D. van der; Curtis, J.
2011
Efficacy Sustained After Dose De-escalation of Certolizumab Pegol in Rheumatoid Arthritis Patients: Post-hoc Analysis of the RAPID 2 Open-label Extension
Other
metadata only
Smolen, J.; Vollenhoven, R. van; Kavanaugh, A.; Fichtner, A.; Strand, V.; Vencovsky, J.; Heijde, D. van der
2011
Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Patients With Rheumatoid Arthritis: 3-Year Data From the RAPID 2 Study
Other
metadata only
Smolen, J.; Vollenhoven, R. van; Kavanaugh, A.; Luijtens, K.; Heijde, D. van der; Curtis, J.
2011
EFFICACY SUSTAINED AFTER DOSE DE-ESCALATION OF CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PATIENTS: POST-HOC ANALYSIS OF THE RAPID 2 OPEN-LABEL EXTENSION
Other
metadata only
Landewe, R.; Keystone, E.; Smolen, J.; Goldring, M.; Guerette, B.; Patra, K.; ... ; Heijde, D. van der
2011
DISCONNECT BETWEEN DISEASE ACTIVITY AND JOINT SPACE NARROWING FOR PATIENTS WITH EARLY RA TREATED WITH ADALIMUMAB PLUS METHOTREXATE BUT NOT METHOTREXATE ALONE: CASE FOR ANTI-TNF CARTILAGE PROTECTION
Other
metadata only
Smolen, J.; Vollenhoven, R. van; Kavanaugh, A.; Fichtner, A.; Strand, V.; Vencovsky, J.; Heijde, D. van der
2011
EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: 3-YEAR DATA FROM THE RAPID 2 STUDY
Other
metadata only
Keystone, E.; Heijde, D. van der; Smolen, J.; Weinblatt, M.; Kvien, T.; Strand, V.; ... ; Combe, B.
2010
Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
Other
metadata only
Keystone, E.; Fleischmann, R.; Smolen, J.; Strand, V.; Landewe, R.; Combe, B.; ... ; Heijde, D. van der
2010
The Efficacy of Certolizumab Pegol Added to Methotrexate is Sustained Over 2 Years in the Treatment of Rheumatoid Arthritis
Other
metadata only
Keystone, E.C.; Fleischmann, R.; Smolen, J.; Strand, V.; Landewe, R.; Combe, B.; ... ; Emery, P.
2010
THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Other
metadata only
